Effects of Different Doses of Virtual Reality Therapy in Chronic Stroke Patients

NCT07656987 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 43

Last updated 2026-06-18

No results posted yet for this study

Summary

This study aimed to compare the effects of different doses of Wii Fit-based virtual reality (VR) therapy added to conventional rehabilitation in patients with chronic stroke. Forty-three patients were randomly assigned to three groups: a control group receiving conventional rehabilitation only (5 days/week, 45 min/session for 4 weeks), a VR3 group receiving conventional rehabilitation plus VR training three days per week (20 min/session, 12 sessions total), and a VR5 group receiving conventional rehabilitation plus VR training five days per week (20 min/session, 20 sessions total). Balance (Berg Balance Scale), functional independence (Functional Independence Measure), stroke-specific quality of life (SS-QOL), static postural alignment (Becure Posture Mobile), and center of pressure measurements (Becure Balance System) were assessed before treatment (T0), after treatment (T1), and at one-month follow-up (T2). This prospective, single-blind, randomized controlled trial was conducted at Istanbul Physical Medicine Rehabilitation Training and Research Hospital.

Conditions

Interventions

BEHAVIORAL

Wii Fit-Based Virtual Reality Balance Training

Nintendo Wii Balance Board-based virtual reality balance training delivered using the Becure Balance System (modified with four 16-bit pressure sensors). Sessions lasted 20 minutes. VR3 group received 3 sessions/week (12 total); VR5 group received 5 sessions/week (20 total) over 4 weeks. Games were applied at beginner difficulty for the first 2 weeks and advanced difficulty for the final 2 weeks, with 2 repetitions per game. All sessions were supervised by a physiotherapist.

BEHAVIORAL

Conventional Physiotherapy and Rehabilitation

Conventional physiotherapy program including neurodevelopmental treatment, strengthening, and balance exercises. Applied to all three groups for 45 min/session, 5 days/week, over 4 weeks. Supervised by a physiotherapist.

Sponsors & Collaborators

  • Istanbul Physical Medicine Rehabilitation Training and Research Hospital

    lead OTHER_GOV

Principal Investigators

  • Fatma Nur Kesiktaş, MD, PhD · Istanbul Physical Medicine Rehabilitation Training and Research Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-08-15
Primary Completion
2026-04-10
Completion
2026-04-10

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07656987 on ClinicalTrials.gov